The 8th Annual Biotherapeutics Analytical Summit brought in a record attendance of over 230 international attendees across this week-long event, with participants coming from 15 countries.
The event, with its hallmark brand of topics on Method Development & Qualification, Advances in Characterization and Comparability & Biosimilarity, and its signature mix of regulators, industry and academia speakers, has come to be known as THE Analytical Summit where attendees can hear and learn about real-life case studies, philosophical concepts and practical approaches that can help scientists advance their molecules from discovery to development and commercialization.
Thank you to all our speakers, sponsors, exhibitors for your support and contributions, and to all our delegates for your participation. The success of this event is largely due to your dedicated participation, from sharing your latest research and data, to actively participating in the roundtable discussions, poster viewing and Q&A during the presentations. We look forward to your joining us again next year in Baltimore, Maryland on March 12-16, 2018!
Check out what our participants say about this year’s event:
“At this Bethesda meeting, CHI attracted top FDA and FDA-associated speakers with other companies are not able to. This is an outstanding achievement of this meeting!”
- Director, Merck
“Excellent overall! Loved the talks by FDA and those familiar with FDA. Case studies sharing expectations of regulators were great.”
- Technical Development, Biogen
“An important and focused meeting”
- Director of R&D, ThermoFisher Scientific
“Able to hear real-life examples and case studies from industry”
- Senior Scientist, MedImmune
“Specific discussions on method qualification and validation strategies were very helpful”
- Director, Analytical Development, KBI Biopharma
“Talks were good, speakers were prepared. I like the mix of case studies and more philosophical approaches”
- Principal Research Scientists, Eli Lilly and Company
“The conference provided a good mixture of topics related to both discovery and development”
- PDMS, Johnson & Johnson
“It is a great forum for sharing scientific knowledge and business processes among the industry”
- Senior Scientist, Abbvie